Robert M. Kirsch
Keine laufenden Positionen mehr
Profil
Robert M.
Kirsch has been Vice President of Regulatory Affairs for TolerRx, Inc. since January 2006.
Prior to that, he was Director of Regulatory Affairs and e-Operations for Serono, Inc. Before that, Mr. He worked for McNeil Laboratories, Ortho Pharmaceuticals and Johnson & Johnson Research.
He has 28 years of experience in regulatory affairs in the Pharmaceutical and Biotechnological industries.
He received a Bachelor's degree in Biology from Wake Forest University.
Ehemalige bekannte Positionen von Robert M. Kirsch
| Unternehmen | Position | Ende |
|---|---|---|
Tolerx, Inc.
 Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | General Counsel | - |
Ausbildung von Robert M. Kirsch
| Wake Forest University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Tolerx, Inc.
Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA. | Health Technology |
